MBX Biosciences (MBX) Income Statement: Revenue & Earnings

MBX Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

MBX Biosciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Revenue & Gross Profit
Revenue	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00
Operating Expenses
Research & Development	57.42	28.53	21.30
Selling, General & Administrative	10.78	6.78	3.86
Operating Expenses	68.19	35.31	25.16
Operating Income	-68.19	-35.31	-25.16
Other Income/Expense
Interest Income	6.27	2.75	0.35
Interest Expense	0.00	0.00	-0.37
Other Income/Expense	6.27	0.00	-0.07
Income
Income Before Tax	-61.92	-32.56	-26.14
Income Tax Expense	0.00	0.00	0.00
Net Income	-61.92	-32.56	-26.14
Net Income - Continuous Operations	-61.92	-32.56	-26.14
Net Income - Discontinued Operations	0.00	0.00	0.00
EBITDA	-67.95	-35.15	-25.11
EBIT	-68.19	-35.31	-25.16
Depreciation & Amortization	0.24	0.16	0.06
Earnings Per Share
Basic EPS	-6.00	-1.00	-39.00
Diluted EPS	-6.00	-1.00	-39.00
Basic Shares Outstanding	10.64	31.85	0.67
Diluted Shares Outstanding	10.64	31.85	0.67